$ICPT Recent Headlines 10 Nasdaq stocks with returns of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 7, 2014 at 10:56 AM

$ICPT Recent Headlines

10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
U.S. stocks end lower; Dow turns negative for the year 3:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 10:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 7:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 12:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 3:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois

Intercept Pharmaceuticals (ICPT) Trading With Heavy Volume Before Market Open 8:34 a.m. Today - TheStreet.com
10-Q: INTERCEPT PHARMACEUTICALS INC 5:24 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog 4:02 p.m. Nov. 6, 2014 - Zacks.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino 9:16 a.m. Sept. 11, 2014 - Seeking Alpha
Cowen Initiates Intercept At Outperform 6:23 a.m. Sept. 5, 2014 - benzinga.com
Insider Buys And Sells: Southern Copper, L Brands 7:28 a.m. Sept. 1, 2014 - Seeking Alpha
Insiders Sold Shares of High-Profile Companies This Week 8:49 a.m. Aug. 30, 2014 - 247WallSt.com
4 Biotechs That Might Be Bought Soon 10:53 a.m. Aug. 29, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 8/27/14: Southern Copper, Republic Services, CIBER, Penn Virginia 10:05 a.m. Aug. 28, 2014 - Seeking Alpha
Gilead: Let's Make A Deal 8:45 a.m. Aug. 28, 2014 - Seeking Alpha
IPO Surge In 2014 Matches Pre-Crash Highs 7:51 p.m. Aug. 27, 2014 - Seeking Alpha
Insider Buys And Sells- Priceline, Southern Copper Corp. 11:17 a.m. Aug. 26, 2014 - Seeking Alpha
3 Biotechs Surging Following InterMune Takeover - Analyst Blog 11:07 a.m. Aug. 26, 2014 - Zacks.com
Conatus Pharmaceuticals Down On Low Enthusiasm For High Risk 4:28 p.m. Aug. 25, 2014 - Seeking Alpha
InterMune Stock Spikes On Rare Big Biotech Buyout 10:40 a.m. Aug. 25, 2014 - Investors Business Daily

FLINT Trial in NASH Published in The Lancet 7:06 p.m. Nov. 6, 2014 - GlobeNewswire
Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences 5:02 a.m. Oct. 31, 2014 - GlobeNewswire
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 7:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 8:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting 5:30 a.m. Oct. 8, 2014 - GlobeNewswire
Quarterly Changes to the NASDAQ Q-50 Index 6:06 a.m. Sept. 15, 2014 - GlobeNewswire
Intercept Pharmaceuticals Recognizes International PBC Day 5:56 a.m. Sept. 12, 2014 - GlobeNewswire
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Intercept to Present at Upcoming Investor Conferences 7:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 8:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 4:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 9:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 9:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 8:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 4:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 6:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 10:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept 7:00 a.m. May 12, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Data Retention: FastGPT’s Detailed Deletion Protocols

In the world of AI-driven applications, data retention has become a hot potato, especially when we're talking about sensitive information like conversation records and audit logs. FastGPT, an open-source AI platform, has decided to tell it like it is by detailing exactly how these data pieces are retained and ultimately booted out. All this info was scattered to the winds...

Aurzen Leverages Basquiat for Art-Infused Projection Line

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

King Risk Partners Expands Mid-Atlantic Presence Boldly

King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...

DELIVAN Unveils Electric Vans and Expansion in Europe

DELIVAN Charging Forward with All-Electric Vans Mark the calendar—September 4, 2026, marked a big day for DELIVAN. The company's foray into the European market is getting serious, splashed across IAA Transportation in all its glory. Unveiling two fresh all-electric production vans, DELIVAN's not just tiptoeing onto the scene; it's diving headfirst into Europe's buzzing...

Orbis Celebrates 20 Years of Eye Care in Macau

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

CRESYN Opens Model Residence: A Peek at City Living

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

EF English Live's Approach to Workplace Confidence

Pioneering English Confidence for the Global Workplace Stepping into a meeting with international partners requires more than just textbook knowledge of English. It's about confidently expressing ideas, adapting on the fly, and engaging with global colleagues. Enter EF English Live, a leader in transforming workplace communication through targeted English learning. Expert...

Mammotome Ramps Up to Tackle Biopsy Needle Shortage

A Needle in High Demand There's no beating around the bush: we're staring at a breast biopsy needle shortage that's tossing the healthcare sector into a tizzy. It’s a sterner cocktail when you think that the procedure's delay isn't just a procedural hiccup. It’s a nerve-wracking limbo for patients teetering on the edge of a potential cancer diagnosis. That's where...

Mental Health Lab Aims to Boost Workforce Resilience

Redefining Workforce Mental Health It’s about time someone shook up how we tackle workforce mental health. Enter Project Healthy Minds and their newly minted Workforce Lab, roping in some of the big dogs like Acast, KPMG, and L'Oréal USA. They've tagged Harvard Business School gurus to churn out data on what helps—or harms—workplace sanity. Finally, a chance to put...

Kyndryl Targets Talent: Equity Awards for New Hires

Kyndryl's Strategic Play with Inducement Awards Today's hot ticket is Kyndryl (NYSE: KD) splashing around some inducement equity awards to reel in new recruits. A massive player in enterprise technology services, Kyndryl isn't just resting on its laurels. They're hunting fresh talent and flashing stock like currency. Welcome to 2026, where stocks aren’t just for Wall...